Abbott Gets a Stent--But What Else?
Executive Summary
Abbott Laboratories has licensed US co-promotion rights to Biocompatibles International's coated stents and certain other interventional vascular products. Abbott already made a bold entry into cardiovascular devices when it bought Perclose Inc., the leader in arterial closure devices. What's next? Perhaps it could buy Boston Scientific, whose full product line would instantly propel Abbott to the top of the interventional cardiology market.